/ /

Kathryn Foxhall
National snapshot of childhood obesity
The last year or so has given the nation mixed pictures on childhood obesity, with plenty of challenges ahead.
MACRA changes physician reimbursement model
The new “MACRA” system, underway as of January 2017, massively changes the way physicians are paid under Medicare and will impact pediatricians indirectly but substantially, say experts.
Time for renewed dialog on vaccines
Will the Trump administration promote vaccine hesitancy or create policies that are less than vaccine friendly? Or will his doubts about vaccines encourage hesitancy?
Trump nominates new leader for CMS
President-elect Donald Trump has announced he will nominate Seema Verma, MPH, a consultant with extensive work in Medicaid in several states, to lead the Centers for Medicare and Medicaid Services (CMS).
Cures Act covers vaccines, ACIP, and more
A congressional fact of life is the dangerous “Christmas tree” bill, which passes with so much on it that many things don’t get the scrutiny they deserve. The 21st Century Cures Act, signed into law by President Obama on December 13, 2016, is such a bill.
Data lacking on labeling of opioids for kids
The US Food and Drug Administration (FDA) recently furthered the discussion of the mind-numbing, myriad issues around the use of opioids in children.
Help for kids with complex conditions
Key members of a House of Representatives health subcommittee say they are determined to push out legislation intended to pay for better care coordination under Medicaid for children with complex medical conditions. However, key questions are who will do that coordination and how the money will flow.
FDA revamps nutrition facts label box
In May 2016, the US Food and Drug Administration (FDA) announced the revamping of the rules for the “nutrition facts” label box on packaged foods, the first major such overall in 20 years.
Update: Medicaid mandates are now final
In late April, the Centers for Medicare and Medicaid Services (CMS) published the final rules for remaking Medicaid managed care, starting a huge reform process that will impact the majority of Medicaid recipients.
Pediatric drug voucher program moves through Congress
The US Food and Drug Administration (FDA) practically pleaded with Congress not to renew a 4-year-old program to give special voucher incentives to companies that develop drugs for rare pediatric diseases, saying it skews the agency’s work away from other priorities.